Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

NCT00306969 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma

Interventions

DRUG: bexarotene
DEVICE: photopheresis

Sponsor

Boston University

Collaborators

[object Object]